ERBB2 and breast cancer: Estrogen and progesterone receptor expression seems to be decreased in PABC compared to that in non-pregnant patients with breast cancer (25% vs. 55% to 60%) [13] probably with no significant difference in overexpression of human epidermal growth factor receptor 2 (HER2) ([14,15], Table 1).